Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiliximab + FCR in Relapsed CLL
NCT00103558Phase 2Completed
- Sponsor
- Biogen
- Start
- Mar 2004
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of lumiliximab in chronic lymphocytic leukemia (CLL), sponsored by Biogen. Started Mar 2004; status: completed.
02
Drugs
lumiliximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00103558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103558.